Assessing Outcomes of Three Different Museum-based Social Prescription Programs in Autistic Adults
Exploring the Feasibility of Social Prescription in People on the Autism Spectrum
1 other identifier
interventional
90
1 country
1
Brief Summary
This study will examine whether visiting the National Taiwan Museum can support the social and emotional well-being of autistic adults. The research team plans to recruit 90 autistic adults aged 18 to 50 from the Department of Psychiatry at National Taiwan University Hospital. Participants must have average-range intellectual ability and be able and willing to complete the study activities and assessments. People with serious physical or mental health conditions that would prevent full participation will not be included. Participants must also agree to audio and video recording during the activities. After an outpatient doctor confirms eligibility, participants will complete questionnaires and choose one of three museum participation options:
- 1.Visit the museum once independently.
- 2.Join five guided museum visits with group discussions.
- 3.Invite a friend to visit the museum together.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 29, 2026
CompletedFirst Posted
Study publicly available on registry
August 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
August 17, 2026
July 1, 2026
3.6 years
July 29, 2026
August 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Activity satisfaction
Participants will also complete an activity evaluation based on the University College London Museum Wellbeing Questionnaire. The questionnaire contains 12 items rated on a five-point scale from "never" to "always." It assesses whether participants: Felt happy. Became absorbed in the activity. Felt comfortable and relaxed. Felt safe and secure. Enjoyed the company of others. Enjoyed talking with other people. Found the activity new and interesting. Enjoyed taking part. Found the activity arrangement engaging. Considered the activity entertaining. Felt confident while participating. Experienced a sense of physical and emotional well-being after the activity. Higher scores suggest greater satisfaction.
Change from baseline to after the intervention
Secondary Outcomes (5)
Loneliness
Change from baseline to after the intervention
Emotional intelligence
Change from baseline to after the intervention
Social interaction anxiety
Change from baseline to after the intervention
Depression
Change from baseline to after the intervention
Anxiety
Change from baseline to after the intervention
Other Outcomes (6)
Autistic characteristics
Change from baseline to after the intervention
Empathy
Change from baseline to after the intervention
Social responsiveness
Change from baseline to after the intervention
- +3 more other outcomes
Study Arms (3)
Independent museum visit
EXPERIMENTALWill visit the museum independently on one occasion
Guided museum visits and group discussions
EXPERIMENTALWill attend five structured museum sessions with a group of approximately 10 to 15 participants. Every session will consist of a guided museum visit followed by a facilitated group discussion.
Museum visit with a friend
EXPERIMENTALWill invite a friend or companion of their choice to visit the museum with them
Interventions
Visit the museum independently on one occasion
Participants will attend five structured museum sessions. Each group will include approximately 10 to 15 participants. Every session will consist of a guided museum visit followed by a facilitated group discussion.
Participants will invite a friend or companion of their choice to visit the museum with them.
Eligibility Criteria
You may qualify if:
- Meet the diagnostic criteria for autism spectrum disorder.
- Have intellectual functioning within the normal range.
- Be willing and able to participate in the study procedures.
- Be willing to attend the relevant museum activities and group discussions, when applicable.
- Agree to audio and video recording during relevant study activities.
You may not qualify if:
- Are unwilling to complete the required assessments.
- Have a serious physical or psychiatric condition that limits their physical stamina, emotional capacity, or ability to understand and complete the study procedures.
- Refuse audio or video recording.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Taiwan Museumcollaborator
- National Taiwan University Hospitallead
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
Related Publications (30)
World Health Organization. (2022). A toolkit on how to implement social prescribing
BACKGROUNDSalovey, P., & Mayer, J. D. (1990). Emotional intelligence. Imagination, Cognition and Personality, 9, 185-211.
BACKGROUNDSaklofske, D. H., Austin, E. J., & Minski, P. S. (2003). Factor structure and validity of a trait emotional intelligence measure. Personality and Individual Differences, 34, 1091-1100.
BACKGROUNDPetrides, K. V., & Furnham, A. (2000). On the dimensional structure of emotional intelligence. Personality and Individual Differences, 29, 313-320.
BACKGROUNDZheng YP, Wei LA, Goa LG, Zhang GC, Wong CG. Applicability of the Chinese Beck Depression Inventory. Compr Psychiatry. 1988 Sep-Oct;29(5):484-9. doi: 10.1016/0010-440x(88)90063-6.
PMID: 3180758BACKGROUNDYadav UN, Paudel G, Ghimire S, Khatiwada B, Gurung A, Parsekar SS, Mistry SK. A rapid review of opportunities and challenges in the implementation of social prescription interventions for addressing the unmet needs of individuals living with long-term chronic conditions. BMC Public Health. 2024 Jan 27;24(1):306. doi: 10.1186/s12889-024-17736-2.
PMID: 38279079BACKGROUNDChrostek E, Teixeira L. Within host selection for faster replicating bacterial symbionts. PLoS One. 2018 Jan 18;13(1):e0191530. doi: 10.1371/journal.pone.0191530. eCollection 2018.
PMID: 29346449BACKGROUNDWilhelm FH, Kochar AS, Roth WT, Gross JJ. Social anxiety and response to touch: incongruence between self-evaluative and physiological reactions. Biol Psychol. 2001 Dec;58(3):181-202. doi: 10.1016/s0301-0511(01)00113-2.
PMID: 11698114BACKGROUNDWildman JM, Moffatt S, Steer M, Laing K, Penn L, O'Brien N. Service-users' perspectives of link worker social prescribing: a qualitative follow-up study. BMC Public Health. 2019 Jan 22;19(1):98. doi: 10.1186/s12889-018-6349-x.
PMID: 30670001BACKGROUNDSimpson S, Furlong M, Giebel C. Exploring the enablers and barriers to social prescribing for people living with long-term neurological conditions: a focus group investigation. BMC Health Serv Res. 2021 Nov 13;21(1):1230. doi: 10.1186/s12913-021-07213-6.
PMID: 34774034BACKGROUNDMulligan K, Bhatti S, Rayner J, Hsiung S. Social Prescribing: Creating Pathways Towards Better Health and Wellness. J Am Geriatr Soc. 2020 Feb;68(2):426-428. doi: 10.1111/jgs.16249. Epub 2019 Dec 16. No abstract available.
PMID: 31840796BACKGROUNDMoffatt S, Steer M, Lawson S, Penn L, O'Brien N. Link Worker social prescribing to improve health and well-being for people with long-term conditions: qualitative study of service user perceptions. BMJ Open. 2017 Jul 16;7(7):e015203. doi: 10.1136/bmjopen-2016-015203.
PMID: 28713072BACKGROUNDMistry SK, Harris E, Li X, Harris MF. Feasibility and acceptability of involving bilingual community navigators to improve access to health and social care services in general practice setting of Australia. BMC Health Serv Res. 2023 May 11;23(1):476. doi: 10.1186/s12913-023-09514-4.
PMID: 37170092BACKGROUNDLuo N, Fones CS, Thumboo J, Li SC. Factors influencing health-related quality of life of Asians with anxiety disorders in Singapore. Qual Life Res. 2004 Mar;13(2):557-65. doi: 10.1023/B:QURE.0000018484.89711.e2.
PMID: 15085928BACKGROUNDKim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011 Sep;168(9):904-12. doi: 10.1176/appi.ajp.2011.10101532. Epub 2011 May 9.
PMID: 21558103BACKGROUNDKiely B, Connolly D, Clyne B, Boland F, O'Donnell P, Shea EO, Smith SM. Primary care-based link workers providing social prescribing to improve health and social care outcomes for people with multimorbidity in socially deprived areas (the LinkMM trial): Pilot study for a pragmatic randomised controlled trial. J Multimorb Comorb. 2021 May 20;11:26335565211017781. doi: 10.1177/26335565211017781. eCollection 2021 Jan-Dec.
PMID: 34094992BACKGROUNDHanlon P, Gray CM, Chng NR, Mercer SW. Does Self-Determination Theory help explain the impact of social prescribing? A qualitative analysis of patients' experiences of the Glasgow 'Deep-End' Community Links Worker Intervention. Chronic Illn. 2021 Sep;17(3):173-188. doi: 10.1177/1742395319845427. Epub 2019 May 3.
PMID: 31053038BACKGROUNDGreenberg DM, Warrier V, Allison C, Baron-Cohen S. Testing the Empathizing-Systemizing theory of sex differences and the Extreme Male Brain theory of autism in half a million people. Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12152-12157. doi: 10.1073/pnas.1811032115. Epub 2018 Nov 12.
PMID: 30420503BACKGROUNDGibson K, Pollard TM, Moffatt S. Social prescribing and classed inequality: A journey of upward health mobility? Soc Sci Med. 2021 Jul;280:114037. doi: 10.1016/j.socscimed.2021.114037. Epub 2021 May 16.
PMID: 34033978BACKGROUNDDrinkwater C, Wildman J, Moffatt S. Social prescribing. BMJ. 2019 Mar 28;364:l1285. doi: 10.1136/bmj.l1285. No abstract available.
PMID: 30923039BACKGROUNDChien IC, Lin CH, Chou YJ, Chou P. Prevalence and incidence of autism spectrum disorders among national health insurance enrollees in Taiwan from 1996 to 2005. J Child Neurol. 2011 Jul;26(7):830-4. doi: 10.1177/0883073810393964. Epub 2011 Apr 1.
PMID: 21460178BACKGROUNDChen YL, Chen WJ, Lin KC, Shen LJ, Gau SS. Prevalence of DSM-5 mental disorders in a nationally representative sample of children in Taiwan: methodology and main findings. Epidemiol Psychiatr Sci. 2019 Jan 30;29:e15. doi: 10.1017/S2045796018000793.
PMID: 30696515BACKGROUNDCarnes D, Sohanpal R, Frostick C, Hull S, Mathur R, Netuveli G, Tong J, Hutt P, Bertotti M. The impact of a social prescribing service on patients in primary care: a mixed methods evaluation. BMC Health Serv Res. 2017 Dec 19;17(1):835. doi: 10.1186/s12913-017-2778-y.
PMID: 29258514BACKGROUNDBrandling, J., & House, W. (2007). Investigation into the feasibility of a social prescribing service in primary care: a pilot project. University of Bath and North East Somerset NHS Primary Care Trust
BACKGROUNDBECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004. No abstract available.
PMID: 13688369BACKGROUNDhttps://www.tandfonline.com/doi/abs/10.1207/s15327752jpa6703_13
BACKGROUNDBeck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
PMID: 3204199BACKGROUNDBaron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001 Feb;31(1):5-17. doi: 10.1023/a:1005653411471.
PMID: 11439754BACKGROUNDAmerican Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC
BACKGROUNDAmerican Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). American Psychiatric Association.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2026
First Posted
August 17, 2026
Study Start
May 1, 2024
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
August 17, 2026
Record last verified: 2026-07